IceCure Medical Ltd (NASDAQ:ICCM – Get Free Report) traded down 0.7% on Monday . The stock traded as low as $0.72 and last traded at $0.74. 717,074 shares were traded during mid-day trading, an increase of 45% from the average session volume of 493,939 shares. The stock had previously closed at $0.74.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the stock. Alliance Global Partners raised their target price on shares of IceCure Medical from $1.90 to $2.90 and gave the company a “buy” rating in a research note on Wednesday, March 20th. HC Wainwright reiterated a “buy” rating and issued a $3.00 target price on shares of IceCure Medical in a research note on Wednesday, June 5th.
View Our Latest Report on IceCure Medical
IceCure Medical Stock Down 0.7 %
IceCure Medical (NASDAQ:ICCM – Get Free Report) last posted its earnings results on Tuesday, May 28th. The company reported ($0.08) EPS for the quarter, hitting analysts’ consensus estimates of ($0.08). The firm had revenue of $0.74 million during the quarter, compared to analysts’ expectations of $0.80 million. IceCure Medical had a negative net margin of 444.30% and a negative return on equity of 101.66%. During the same quarter in the prior year, the business earned ($0.08) earnings per share. On average, equities research analysts expect that IceCure Medical Ltd will post -0.28 earnings per share for the current year.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Featured Stories
- Five stocks we like better than IceCure Medical
- Upcoming IPO Stock Lockup Period, Explained
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Roth IRA Calculator: Calculate Your Potential Returns
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- What is Short Interest? How to Use It
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.